Mineralys Therapeutics (MLYS) Payables (2022 - 2026)
Quarterly results put Payables at $1.1 million for Q1 2026, up 199.2% from a year ago — trailing twelve months through Mar 2026 was $1.1 million (up 199.2% YoY), and the annual figure for FY2025 was $2.0 million, up 321.09%.
Mineralys Therapeutics has reported Payables over the past 5 years, most recently at $1.1 million for Q1 2026.
- Payables reached $1.1 million in Q1 2026 per MLYS's latest filing, down from $2.0 million in the prior quarter.
- Across five years, Payables topped out at $5.6 million in Q3 2023 and bottomed at $373000.0 in Q1 2025.
- Median Payables over the past 5 years was $2.0 million (2022), compared with a mean of $2.1 million.
- Peak annual rise in Payables hit 321.09% in 2025, while the deepest fall reached 91.25% in 2025.
- Over 5 years, Payables stood at $1.9 million in 2022, then tumbled by 68.48% to $601000.0 in 2023, then decreased by 20.3% to $479000.0 in 2024, then skyrocketed by 321.09% to $2.0 million in 2025, then tumbled by 44.67% to $1.1 million in 2026.
- Business Quant data shows Payables for MLYS at $1.1 million in Q1 2026, $2.0 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 373,000.00 |
| Dec 31, 2024 | 479,000.00 |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 601,000.00 |
| Sep 30, 2023 | 5.57 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.39 Mn |
| Dec 31, 2022 | 1.91 Mn |